CSIMarket
 


Moderna Inc.  (MRNA)
Other Ticker:  
 


Moderna's Pre-Tax Profit Margin by quarter

Trends, Rankings, Statistics



MRNA Pre-Tax Profit Margin (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change 9.07 % 213.16 % 1163.44 % 3046.73 % 6462.07 %
Seq. Revenue Change -21.71 % -15.88 % 45.12 % 14.12 % 124.78 %
Revenue In Millions $4,749.00 $6,066.00 $7,211.00 $4,969.00 $4,354.00
Pre-Tax Profit Margin 52.1 % 69.72 % 75.02 % 71.48 % 70.35 %
Pre-Tax Profit Margin Total Ranking # 288 # 182 # 195 # 198 # 174
Pre-Tax Income In Millions $2,474.00 $4,229.00 $5,410.00 $3,552.00 $3,063.00
Y / Y Pre-Tax Income Change -19.23 % 235.63 % - - -
Seq. Pre-Tax Income Change -41.5 % -21.83 % 52.31 % 15.96 % 143.1 %


Commenting Second Quarter 2022 Pre-Tax Profit Margin
Moderna Inc. experienced contraction in Pre-Tax Income by -41.5 % to $4,749 millions and Revenue by -21.71 %, while Pre-Tax Profit Margin fell to 52.1 % a new company low.

Observing second quarter 2022 results within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Pre-Tax Profit Margin. While Pre-Tax Profit Margin overall ranking has deteriorated compare to previous quarter from 182 to 288.

MRNA's Pre-Tax Profit Margin second quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 20
Overall # 288

Pre-Tax Profit Margin Statistics
High Average Low
961.25 % 261.04 % 52.1 %
(Sep 30 2015)   (Jun 30 2022)




Other Pre-Tax Profit Margin Profitability Ratios
MRNA's Cumulative Pre-Tax Profit Margin
Biotechnology & Pharmaceuticals Industry Pre-Tax Profit Margin Trends and Statistics
Healthcare Sector Pre-Tax Profit Margin Statistics
Pre-Tax Profit Margin Profitability Trends for overall market
MRNA's Pre-Tax Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Pre-Tax Profit Margin
Lowest Ranking Pre-Tax Profit Margin
Pre-Tax Profit Margin Profit Margin for MRNA's Competitors
Pre-Tax Profit Margin Profit Margin for Moderna's Suppliers
Pre-Tax Profit Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Pre-Tax Income Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar Pre-Tax Profit Margin in the quarter ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Pre-Tax Profit MarginJun 30 2022 MRQ Pre-Tax IncomeJun 30 2022 MRQ Revenue
Enact Holdings Inc.  95.37 %$ 260.887 $ 273.541 
Royalty Pharma Plc  91.72 %$ 491.597 $ 535.955 
Moderna Inc.  52.10 %$ 2,474.000 $ 4,749.000 
Biogen Inc.  49.03 %$ 1,269.500 $ 2,589.100 
Atara Biotherapeutics Inc.  35.80 %$ 18.466 $ 51.579 
Repligen Corp  28.78 %$ 59.756 $ 207.633 
Bio techne Corp  27.43 %$ 79.052 $ 288.228 
Gilead Sciences Inc.  24.01 %$ 1,503.000 $ 6,260.000 
Axon Enterprise inc.  23.96 %$ 68.437 $ 285.613 
La Jolla Pharmaceutical Company  23.48 %$ 2.475 $ 10.543 
Iteos Therapeutics Inc.  20.24 %$ 8.443 $ 41.716 
Halozyme Therapeutics Inc.  19.70 %$ 30.011 $ 152.365 
Avantor Inc.  11.85 %$ 226.300 $ 1,910.500 
Fulgent Genetics Inc.  10.97 %$ 13.752 $ 125.341 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HDSI's Profile

Stock Price

HDSI's Financials

Business Description

Fundamentals

Charts & Quotes

HDSI's News

Suppliers

HDSI's Competitors

Customers & Markets

Economic Indicators

HDSI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071